Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
48-Hour Action Plan: Patient Safety First, Managed Transparency Second Core Decision (Stated Up Front) We report to regulators immediately—voluntarily—and we disclose on the earnings call. The math is brutal and clear: ~500 patients could develop liver failure over 5 years at current prescribing rates (4M ÷ 8,000).Read the full answer
Executive Decision: The "Safety First" Protocol My Core Philosophy: In pharmaceuticals, trust is our only currency. If we lose patient trust or regulatory standing, the $2B revenue becomes irrelevant. Hiding this data is not a business strategy; it is a liability waiting to explode.Read the full answer